| |
| |
|
| Insider
Information: |
Nicholson Nur |
| Relationship: |
Chief Technical Officer |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
56,287 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,470,999 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,287 |
|
|
| Total
Value |
$2,470,999 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Technical Officer |
2024-03-13 |
56,287 |
2021-01-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2024-03-13 |
4 |
S |
$57.31 |
$645,838 |
D/D |
(11,220) |
56,287 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2024-01-29 |
4 |
S |
$64.14 |
$53,555 |
D/D |
(835) |
67,507 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2024-01-22 |
4 |
S |
$65.00 |
$168,535 |
D/D |
(2,593) |
68,342 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2024-01-16 |
4 |
S |
$66.81 |
$124,064 |
D/D |
(1,857) |
70,935 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
19,508 |
72,792 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2023-09-18 |
4 |
S |
$42.21 |
$900,813 |
D/D |
(20,350) |
53,284 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2023-09-18 |
4 |
OE |
$29.76 |
$289,237 |
D/D |
9,719 |
73,634 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• – – |
2023-02-21 |
4 |
D |
$58.50 |
$48,263 |
D/D |
(825) |
63,503 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• – – |
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
9,886 |
64,328 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2023-01-27 |
4 |
D |
$52.77 |
$29,076 |
D/D |
(551) |
54,442 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2023-01-20 |
4 |
D |
$52.05 |
$105,870 |
D/D |
(2,034) |
54,993 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
22,580 |
57,027 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2022-04-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,875) |
33,680 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2022-01-28 |
4 |
D |
$38.59 |
$25,084 |
D/D |
(650) |
35,555 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2022-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
26,051 |
36,205 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Technical Officer |
• • – |
2021-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
9,375 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
